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Scientific objectives
Diabetes is considered as a risk factor for atrial fibrilla-
tion and patients with a co morbidity of diabetes and
atrial fibrillation have an increased risk of cardio-vascu-
lar complications like stroke. However, paroxysmal atrial
fibrillation often is not recognized and therefore stroke
is a frequent and severe complication of diabetes and
atrial fibrillation. The objective of the study is a screen-
ing of patients with diabetes mellitus type 2 for atrial
fibrillation and as a consequence an individually
adjusted risk management regarding glucoses levels,
anticoagulation and blood pressure.
Technical approaches
To detect atrial fibrillation ECGs of diabetes patients
will be evaluated by an automated AF episode detection
algorithm that already has proven superiority in the
detection of atrial fibrillation. The software uses an algo-
rithm that detects QRS complexes of the ECG data and
then classifies them as being of atrial or ventricular ori-
gin and finally creates a list of R-R-intervals. To detect
episodes of AF, the software performs a time series ana-
lysis of multiple mathematical parameters that are typi-
cal for an absolute arrhythmia during AF. Based on this
analysis, the system creates a report on whether epi-
sodes of AF are present [2]. The procedure is suggested
to be applied in a multi-center study and will be used as
a basis for the design and evaluation of an individually
risk adjusted medication of patients. This will especially
combine glucose level and blood pressure control and
anticoagulation strategies.
Expected results
The study is expected to give detailed information on
the increased prevalence of atrial fibrillation in patients
with type 2 diabetes and provides the data base for an
optimized therapy regime in order to avoid cardio-vas-
cular complications.
Outlook and recommendations
The detection of atrial fibilation as a major risk factor
for cardio-vascular complications of diabetic patients
will have to be improved. This strategy can be combined
with other strategies of detection of complication risks
(especially proteomics) and improve personalized treat-
ment of diabetic patients.
Authors’ details
1Endocrinology and metabolic diseases, University Medicine Mainz, Johannes
Gutenberg-Universität, Langenbeckstraße 1, 55131 Mainz, Germany. 2Institut
Arbeit und Technik, Munscheidstr. 14, 45886 Gelsenkirchen, Germany.
Published: 11 February 2014
References
1. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB,
Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-
Morton DG, Friedewald WT: Action to Control Cardiovascular Risk in
Diabetes Study Group. N Engl J Med 2008, 358:2545-59.
2. Rizos T, Gutner J, Jenetzky E, Marquardt L, et al: Continuous Stroke Unit
Electrocardiographic Monitoring Versus 24-Hour Holter
Electrocardiography for Detection of Paroxysmal Atrial Fibrillation After
Stroke. Stroke 2012, 43:2689-2694.
doi:10.1186/1878-5085-5-S1-A71
Cite this article as: Weber and von Bandemer: Risk detection and risk
management for diabetes patients with atrial fibrilation. EPMA Journal
2014 5(Suppl 1):A71.
* Correspondence: mmweber@uni-mainz.de
1Endocrinology and metabolic diseases, University Medicine Mainz, Johannes
Gutenberg-Universität, Langenbeckstraße 1, 55131 Mainz, Germany
Full list of author information is available at the end of the article
Weber and von Bandemer EPMA Journal 2014, 5(Suppl 1):A71
http://www.epmajournal.com/content/5/S1/A71
© 2014 Weber and von Bandemer; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
